Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105873897B reveals mild amine synthesis. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN112661744B reveals an isothermal purification method for Esomeprazole Sodium, achieving >99.5% purity with minimal R-enantiomer. Ideal for reliable pharmaceutical intermediate supply chains.
Discover an efficient 3-step synthesis for 1-Boc-3-fluoroazetidine-3-carboxylic acid. This patent offers high yield and scalable production for API manufacturing.
Patent CN104356140B details membrane separation for Moxidectin. Achieve higher purity and lower costs in veterinary drug manufacturing with scalable technology.
Patent CN1144796C details a high-yield route for 2R-propyl octanoic acid intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN103724336A details a novel Rivaroxaban synthesis using CDI or DCC condensing agents, offering superior yield and cost efficiency for pharmaceutical manufacturing.
Discover the advanced CN101717352B synthesis method for Agmatine Sulfate. We offer cost-effective, eco-friendly manufacturing solutions for reliable pharmaceutical intermediate supply chains.
Patent CN101817795A details a tin-free valsartan synthesis with high purity. Discover cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN101717352A reveals a clean synthesis route for agmatine sulfate using O-methylisourea sulfate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1034806C reveals a novel route for pyrimidinetrione derivatives, offering high purity and cost reduction in API manufacturing through improved selectivity.
Novel synthesis route for cefcapene diisopropylamine salt ensures high purity and cost efficiency for global antibiotic supply chains.
Novel synthesis method for Pitavastatin Calcium intermediate offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN107641130A reveals a stable D-Sulbenicillin Sodium synthesis route ensuring high optical purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107759472A reveals a high-yield synthetic route for Scutellarin intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN114773354B reveals a green two-step synthesis for Trisphaeridine. Discover cost-effective manufacturing and scalable supply chain solutions for this anticancer intermediate.
Novel 3-step synthesis for Dapagliflozin ensures high yield and purity. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Novel 3-step synthesis of Eldecalcitol 20S isomer via silyl protection and coupling. Offers high yield over 65 percent and cost-effective scale-up for pharmaceutical impurity standards.
Patent CN120923436A reveals a low-cost synthesis route for Fluralaner intermediates. Enhance supply chain reliability and purity with scalable veterinary drug solutions.
Patent CN114605311B reveals a cost-effective route to 6,6-dimethyl-3-azabicyclo[3.1.0]hexane using cheap starting materials, offering significant supply chain advantages.